Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer (PC03)
Pancreatic Cancer
About this trial
This is an interventional treatment trial for Pancreatic Cancer focused on measuring Proton radiation, Chemotherapy, Pancreatic cancer, Postoperative
Eligibility Criteria
Inclusion Criteria:
- Histologic proof of primary head of pancreas invasive adenocarcinoma managed with a potentially curative resection
- Post resection CA19-9 tumor marker baseline
Exclusion Criteria:
- Previous history of invasive malignancy (except non-melanoma skin cancer and low to intermediate risk prostate cancer) unless the patient has been disease free for at least 5 years prior to study consent
Sites / Locations
- University of Florida Proton Therapy Institute
- Provision Proton Therapy Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
1- R(0) negative
2- R(1) micro-positive
3- R(2) gross positive
50.40 cobalt gray equivalent (CGE) Proton Radiation and concomitant chemotherapy with weekly gemcitabine
54.00 cobalt gray equivalent(CGE) Proton Radiation and concomitant chemotherapy with weekly gemcitabine
59.40 cobalt gray equivalent (CGE) Proton Radiation and concomitant chemotherapy with weekly gemcitabine